| Assoc Prof (Adj) Charles William Johannes
Adjunct Associate Professor
Division of Chemistry & Biological Chemistry
School of Physical & Mathematical Sciences
College of Science
Email: CJOHANNES@ntu.edu.sg
Phone: (+65)63168908
Office: SPMS-CBC-02-01 |
| Education |
- PhD (Organic Chem) Boston College, Boston 1998
- BA (Chem) Guilford College, Greensboro 1993
|
| Biography |
| Dr. Johannes is Director of Forma Therapeutics working in collaboration with NTU under an MOU and is serving as Adjunct Assistant Professor. Prior to joining NTU and Forma Therapeutics, Dr. Johannes was the Associate Director of Chemistry at Infinity Pharmaceuticals. Dr. Johannes was involved in early lead discovery for oncology and most recently responsible for leading the Diversity Oriented Chemistry platform. Dr. Johannes was responsible for managing a team of 22 scientists and collaborations with Amgen, Johnson and Johnson, and Novartis which generated >$50 million in revenue and >200,000 complex diversity oriented synthesis compounds. Prior to Infinity Dr. Johannes was involved in de novo natural product synthesis for lead discovery in oncology and inflammation at Eisai Research Institute. Dr. Johannes received his Ph.D. at Boston College developing asymmetric catalytic carbon-carbon bond forming reactions and applied these methodologies to natural product total synthesis and a B.S. from Guilford College. |
| Research Interests |
| My research is focused on employing enantioselective methodologies and synthetic natural product strategies in the development of a Diversity Oriented Synthesis (DOS) approach to generate innovative chemical matter for novel therapeutic medicines. |